骨扫描检测到晚期乳腺癌患者发生双膦酸盐相关颌骨骨坏死：一例报告
Bisphosphonate-related osteonecrosis of jaws in advanced stage breast cancer was detected from bone scan: a case report.
作者信息
Chirappapha Prakasit, Kitudomrat Saowanee, Thongjood Thanaporn, Aroonroch Rangsima
机构信息
Department of Surgery, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Dental Department, Faculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
出版信息
Gland Surg. 2017 Feb;6(1):93-100. doi: 10.21037/gs.2016.07.04.
Abstract
Bisphosphonates (BPs) are indicated to treat skeletal-related events (SREs) for cancer patients with bone metastasis. We report a 79-year-old woman with advanced stage breast cancer with bone metastasis who was prescribed BPs (zoledronate), then developed osteonecrosis of jaw. We provide a brief review of the pathogenesis, diagnosis and treatment of this complication.
摘要
双膦酸盐类药物（BPs）被用于治疗骨转移癌患者的骨相关事件（SREs）。我们报告了一名79岁晚期乳腺癌伴骨转移的女性患者，她接受了BPs（唑来膦酸）治疗，随后发生了颌骨坏死。我们对该并发症的发病机制、诊断和治疗进行简要综述。
相似文献
1
Bisphosphonate-related osteonecrosis of jaws in advanced stage breast cancer was detected from bone scan: a case report.骨扫描检测到晚期乳腺癌患者发生双膦酸盐相关颌骨骨坏死：一例报告
Gland Surg. 2017 Feb;6(1):93-100. doi: 10.21037/gs.2016.07.04.
2
Bisphosphonate-associated osteonecrosis: a clinician's reference to patient management.双膦酸盐相关骨坏死：临床医生患者管理参考
Todays FDA. 2008 Aug;20(8):38-41, 43-6.
3
Osteonecrosis of the jaw: effect of bisphosphonate type, local concentration, and acidic milieu on the pathomechanism.颌骨骨坏死：双膦酸盐类型、局部浓度及酸性环境对发病机制的影响
J Oral Maxillofac Surg. 2010 Nov;68(11):2837-45. doi: 10.1016/j.joms.2010.07.017.
4
Jaw avascular osteonecrosis after treatment of multiple myeloma with zoledronate.唑来膦酸治疗多发性骨髓瘤后颌骨缺血性骨坏死
J Plast Reconstr Aesthet Surg. 2008;61(1):99-106. doi: 10.1016/j.bjps.2006.06.016. Epub 2006 Sep 12.
5
[Bisphosphonate related osteonecrosis of the jaws: a case report and review of the literature].[双膦酸盐相关颌骨坏死：一例病例报告及文献综述]
Shanghai Kou Qiang Yi Xue. 2012 Jun;21(3):354-8.
6
Bisphosphonate-related osteonecrosis of the jaws: Report of a case using conservative protocol.双膦酸盐相关颌骨骨坏死：采用保守方案的病例报告。
Spec Care Dentist. 2016 Jan;36(1):43-7. doi: 10.1111/scd.12143. Epub 2015 Nov 24.
7
Prolonged administration of bisphosphonates is well-tolerated and effective for skeletal-related events in Chinese breast cancer patients with bone metastasis.长期使用双磷酸盐可有效耐受，并可减少中国乳腺癌伴骨转移患者的骨骼相关事件。
Breast. 2012 Aug;21(4):544-9. doi: 10.1016/j.breast.2012.04.008. Epub 2012 May 22.
8
Concept, diagnosis and classification of bisphosphonate-associated osteonecrosis of the jaws. A review of the literature.双膦酸盐相关颌骨坏死的概念、诊断与分类。文献综述
Med Oral Patol Oral Cir Bucal. 2016 May 1;21(3):e260-70. doi: 10.4317/medoral.21001.
9
[A case of bisphosphonate-related osteonecrosis of the jaw in a patient who had received intravenous bisphosphonates].[一例接受静脉注射双膦酸盐治疗的患者发生双膦酸盐相关颌骨坏死]
Gan To Kagaku Ryoho. 2014 Feb;41(2):225-7.
10
[A case of osteonecrosis of the lower jaw due to bisphosphonates in a breast cancer patient with bone metastasis].[一名患有骨转移的乳腺癌患者因双膦酸盐导致下颌骨坏死的病例]
Gan To Kagaku Ryoho. 2008 Nov;35(11):1973-5.
引用本文的文献
1
Risk factors associated with onset of medication-related osteonecrosis of the jaw in patients treated with denosumab.与接受地舒单抗治疗的患者发生药物相关性颌骨坏死相关的风险因素。
Clin Oral Investig. 2022 Mar;26(3):2839-2852. doi: 10.1007/s00784-021-04261-4. Epub 2021 Nov 23.
2
Extensive protein expression changes induced by pamidronate in RAW 264.7 cells as determined by IP-HPLC.通过免疫沉淀-高效液相色谱法测定，帕米膦酸盐诱导RAW 264.7细胞中出现广泛的蛋白质表达变化。
PeerJ. 2020 May 21;8:e9202. doi: 10.7717/peerj.9202. eCollection 2020.
本文引用的文献
1
Bisphosphonate-related osteonecrosis of the jaws: Report of a case using conservative protocol.双膦酸盐相关颌骨骨坏死：采用保守方案的病例报告。
Spec Care Dentist. 2016 Jan;36(1):43-7. doi: 10.1111/scd.12143. Epub 2015 Nov 24.
2
Bisphosphonate Related Osteonecrosis of the Jaw: An Update.双膦酸盐相关颌骨坏死：最新进展
J Maxillofac Oral Surg. 2014 Dec;13(4):386-93. doi: 10.1007/s12663-013-0564-x. Epub 2013 Aug 9.
3
Bisphosphonate-related osteonecrosis of the jaw: specificities.双膦酸盐相关颌骨坏死：特点
Oncol Rev. 2014 Sep 23;8(2):254. doi: 10.4081/oncol.2014.254.
4
RANK/RANKL/OPG signaling pathways in necrotic jaw bone from bisphosphonate-treated subjects.双膦酸盐治疗患者坏死颌骨中的RANK/RANKL/OPG信号通路
Eur J Histochem. 2015 Feb 3;59(1):2455. doi: 10.4081/ejh.2015.2455.
5
American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw--2014 update.美国口腔颌面外科医师协会关于药物相关性颌骨坏死的立场文件——2014年更新版
J Oral Maxillofac Surg. 2014 Oct;72(10):1938-56. doi: 10.1016/j.joms.2014.04.031. Epub 2014 May 5.
6
Bisphosphonate-related osteonecrosis of the jaws: analysis of a case series at a dental school.双膦酸盐相关颌骨坏死：一所牙科学院的病例系列分析
Spec Care Dentist. 2014 Mar-Apr;34(2):77-83. doi: 10.1111/scd.12023.
7
Platelet-rich plasma (PRP) in dental and oral surgery: from the wound healing to bone regeneration.富血小板血浆（PRP）在口腔和口腔颌面外科中的应用：从伤口愈合到骨再生。
Immun Ageing. 2013 Jun 13;10(1):23. doi: 10.1186/1742-4933-10-23.
8
Evolution and etiopathogenesis of bisphosphonates induced osteonecrosis of the jaw.双膦酸盐类药物所致颌骨坏死的演变及发病机制
N Am J Med Sci. 2013 Apr;5(4):260-5. doi: 10.4103/1947-2714.110429.
9
Allogeneic mesenchymal stem cell therapy for bisphosphonate-related jaw osteonecrosis in Swine.同种异体间充质干细胞治疗猪的双膦酸盐相关性颌骨骨坏死。
Stem Cells Dev. 2013 Jul 15;22(14):2047-56. doi: 10.1089/scd.2012.0615. Epub 2013 Apr 6.
10
Bisphosphonate-related osteonecrosis of the jaw (BRONJ): 5 year experience in the treatment of 131 cases with ozone therapy.双膦酸盐相关性颌骨坏死（BRONJ）：臭氧治疗 131 例 5 年经验。
Eur Rev Med Pharmacol Sci. 2012 Nov;16(12):1741-7.
Zotero 插件